Vol. 1 No. 11 (2005) | Hematology Meeting Reports

Current Issue

Vol. 1 No. 11 (2005)

5 June 2009

View this Issue

Vol. 1 No. 11 (2005)

Published: 5 June 2009

Thalidomide in the treatment of multiple myeloma, Sydney, 10 April 2005

Abstracts

Introduction

Douglas E. Joshua

https://doi.org/10.4081/hmr.v1i11.349

205

PDF: 178
- PDF
Thalidomide alone or in combination: results in refractory patients

Jesús F. San Miguel

https://doi.org/10.4081/hmr.v1i11.350

309

PDF: 439
- PDF
Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan and prednisone versus melphalan, prednisone, and thalidomide

Mario Boccadoro

https://doi.org/10.4081/hmr.v1i11.351

230

PDF: 240
- PDF
The Intergroupe Francophone du Myélome experience with thalidomide

Jean-Luc Harousseau, Michel Attal, Thierry Facon, Ibrahim Yakoub-Agha

https://doi.org/10.4081/hmr.v1i11.352

283

PDF: 346
- PDF
Thalidomide plus dexamethasone as initial therapy for multiple myeloma: overview of Mayo Clinic and Eastern Cooperative Oncology Group experience

Robert A. Kyle, Vincent Rajkumar

https://doi.org/10.4081/hmr.v1i11.353

224

PDF: 342
- PDF
Panel Discussion

Dr. Joshua

https://doi.org/10.4081/hmr.v1i11.354

208

PDF: 235
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.